The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

Dystrophin's isoforms are thought to contribute variably to neuropsychiatric disorders, behavioral disorders, and ...

For many, a visit to the dentist brings fear, anxiety, or memories of uncomfortable experiences. But dentistry is ...

There is no known cure for Duchenne muscular dystrophy and currently approved treatment aims to control symptoms to improve quality of life. Sarepta Therapeutics’ Exondys 51 (eteplirsen ...

In many genetic diseases, a small error in the DNA code can have devastating effects. These errors, called nonsense mutations ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Access is especially tough for kids in rural areas or whose families don't have a lot of money. Some dentists say a new ...

Repurposing existing therapies may help slow muscle weakness in patients with Duchenne muscular dystrophy, a new study ...

Interim results from a small group of children in a Phase I/II trial are essentially in line with that of Elevidys, according ...